{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:33:04Z","timestamp":1790267584950,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00091","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T03:37:22Z","timestamp":1490845042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington\u2019s Disease: Are They Fit-for-Purpose for Treatment Development?"],"prefix":"10.3389","volume":"8","author":[{"given":"Michael K.","family":"Leuchter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa J.","family":"Donzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Estrada-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Leuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.31887\/DCNS.2014.16.4\/aleuchter","article-title":"Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder","volume":"16","author":"Leuchter","year":"2014","journal-title":"Dialogues Clin Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2012.121","article-title":"An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity","volume":"3","author":"Cisbani","year":"2012","journal-title":"Cell Death Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI45364","article-title":"The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease","volume":"121","author":"Munoz-Sanjuan","year":"2011","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1021\/jm3015926","article-title":"Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers","volume":"56","author":"Trippier","year":"2013","journal-title":"J Med Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"RRN1182","DOI":"10.1371\/currents.RRN1182","article-title":"Rescuing the corticostriatal synaptic disconnection in the R6\/2 mouse model of Huntington\u2019s disease: exercise, adenosine receptors and ampakines","volume":"2","author":"Cepeda","year":"2010","journal-title":"PLoS Curr"},{"key":"B7","author":"Macdonald","year":"2015","journal-title":"Pharmacodynamic Biomarkers for HTT-Lowering Therapies. A White Paper. Huntingtin-Lowering Biomarker Project Team: Huntingtin-Lowering Biomarker Task Force Committee Members"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JHD-130050","article-title":"Large genetic animal models of Huntington\u2019s disease","volume":"2","author":"Morton","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.2147\/DDDT.S58470","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/mds.26008","article-title":"Mind the gap: models in multiple species needed for therapeutic development in Huntington\u2019s disease","volume":"29","author":"Howland","year":"2014","journal-title":"Mov Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington\u2019s disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1152\/jn.00762.2011","article-title":"A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of Huntington\u2019s disease","volume":"107","author":"Cummings","year":"2012","journal-title":"J Neurophysiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in Mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.expneurol.2014.10.001","article-title":"Application of neurophysiological biomarkers for Huntington\u2019s disease: evaluating a phosphodiesterase 9A inhibitor","volume":"263","author":"Nagy","year":"2015","journal-title":"Exp Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5665\/sleep.5448","article-title":"Quantitative electroencephalographic analysis provides an early-stage indicator of disease onset and progression in the zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"39","author":"Fisher","year":"2016","journal-title":"Sleep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/brain\/awt132","article-title":"Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mouse model of Huntington\u2019s disease","volume":"136","author":"Fisher","year":"2013","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/brain\/awt128","article-title":"Progressive sleep and electroencephalogram changes in mice carrying the Huntington\u2019s disease mutation","volume":"136","author":"Kantor","year":"2013","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuropharm.2016.01.027","article-title":"A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington\u2019s disease mice","volume":"105","author":"Kantor","year":"2016","journal-title":"Neuropharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1113\/JP270268","article-title":"Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6\/2 mouse model of Huntington\u2019s disease","volume":"16","author":"Callahan","year":"2015","journal-title":"J Physiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnsys.2011.00026","article-title":"Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington\u2019s disease","volume":"5","author":"Miller","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1317\/journal.pone.0047026","article-title":"Dysfunctional behavioral modulation of corticostriatal communication in the R6\/2 mouse model of Huntington\u2019s disease","volume":"7","author":"Hong","year":"2012","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fnbeh.2015.00361","article-title":"Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD","volume":"9","author":"Curtin","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8986","DOI":"10.1523\/JNEUROSCI.1238-11.2011","article-title":"Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for Huntington disease","volume":"31","author":"H\u00f6hn","year":"2011","journal-title":"J Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.drudis.2014.03.002","article-title":"Biomarker development for Huntington\u2019s disease","volume":"19","author":"Andre","year":"2014","journal-title":"Drug Discov Today"},{"key":"B26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","article-title":"Development of biomarkers for Huntington\u2019s disease","volume":"10","author":"Weir","year":"2011","journal-title":"Lancet Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of Huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/hmg\/ddq063","article-title":"An ovine transgenic Huntington\u2019s disease model","volume":"19","author":"Jacobsen","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/brain\/awv026","article-title":"Translational neurophysiology in sheep: measuring sleep and neurological dysfunction in CLN5 Batten disease affected sheep","volume":"138","author":"Perentos","year":"2015","journal-title":"Brain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.physbeh.2016.05.028","article-title":"Automated detection and characterisation of rumination in sheep using in vivo electrophysiology","volume":"163","author":"Nicol","year":"2016","journal-title":"Physiol Behav"},{"key":"B32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JHD-130067","article-title":"Further molecular characterisation of the OVT73 transgenic sheep model of Huntington\u2019s disease identifies cortical aggregates","volume":"2","author":"Reid","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"20681","DOI":"10.1038\/srep20681","article-title":"Metabolic disruption identified in the Huntington\u2019s disease transgenic sheep model","volume":"6","author":"Handley","year":"2016","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1093\/hmg\/ddu047","article-title":"Early and progressive circadian abnormalities in Huntington\u2019s disease sheep are unmasked by social environment","volume":"23","author":"Morton","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/JHD-130001","article-title":"A transgenic minipig model of Huntington\u2019s disease","volume":"2","author":"Baxa","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneumeth.2015.11.017","article-title":"Neuroimaging of a minipig model of Huntington\u2019s disease: feasibility of volumetric, diffusion-weighted and spectroscopic assessments","volume":"265","author":"Schubert","year":"2015","journal-title":"J Neurosci Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jneumeth.2015.11.013","article-title":"Behavioral phenotyping of minipigs transgenic for the Huntington gene","volume":"265","author":"Schramke","year":"2015","journal-title":"J Neurosci Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.theriogenology.2015.03.016","article-title":"Germline transmission in transgenic Huntington\u2019s disease monkeys","volume":"84","author":"Moran","year":"2015","journal-title":"Theriogenology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/journal.pone.0122335","article-title":"Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic huntington disease monkey model from infancy to adulthood","volume":"10","author":"Chan","year":"2015","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2202-15-36","article-title":"A two years longitudinal study of a transgenic huntington disease monkey","volume":"15","author":"Chan","year":"2014","journal-title":"BMC Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.24495","article-title":"Sleep deficits but no metabolic deficits in premanifest Huntington\u2019s disease","volume":"78","author":"Lazar","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"B42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1550059416632413","article-title":"Wake and sleep EEG in patients with Huntington disease: an eLORETA study and review of the literature","volume":"48","author":"Piano","year":"2016","journal-title":"Clin EEG Neurosci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jns.2014.06.035","article-title":"Alpha-theta border EEG abnormalities in preclinical Huntington\u2019s disease","volume":"344","author":"Ponomareva","year":"2014","journal-title":"J Neurol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s00415-010-5852-5","article-title":"EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington\u2019s disease","volume":"258","author":"Painold","year":"2011","journal-title":"J Neurol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"RRN1192","DOI":"10.1371\/currents.RRN1192","article-title":"QEEG measures in Huntington\u2019s disease: a pilot study","volume":"2","author":"Hunter","year":"2010","journal-title":"PLoS Curr"},{"key":"B46","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mds.21390","article-title":"Memory activation reveals abnormal EEG in preclinical Huntington\u2019s disease","volume":"22","author":"Van Der Hiele","year":"2007","journal-title":"Mov Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S1388-2457(03)00074-9","article-title":"Detection of subclinical brain electrical activity changes in Huntington\u2019s disease using artificial neural networks","volume":"114","author":"De Tommaso","year":"2003","journal-title":"Clin Neurophysiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0028-3932(94)90001-9","article-title":"EEG power spectra in Huntington\u2019s disease: clinical and neuropsychological correlates","volume":"32","author":"Bylsma","year":"1994","journal-title":"Neuropsychologia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00702-010-0491-7","article-title":"Comparative EEG mapping studies in Huntington\u2019s disease patients and controls","volume":"117","author":"Painold","year":"2010","journal-title":"J Neural Transm"},{"key":"B50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/nyas.12742","article-title":"Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments","volume":"1344","author":"Leuchter","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jpsychires.2016.10.002","article-title":"Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder","volume":"84","author":"Leuchter","year":"2017","journal-title":"J Psychiatr Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s004010050408","article-title":"Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington\u2019s disease","volume":"91","author":"Heinsen","year":"1996","journal-title":"Acta Neuropathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s004010051037","article-title":"Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease","volume":"97","author":"Heinsen","year":"1999","journal-title":"Acta Neuropathol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00091\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T01:21:46Z","timestamp":1658884906000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00091\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00091","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,30]]}}}